A National Phase IV Study With Ipilimumab for Patients With Advanced Malignant Melanoma.
A National Phase IV Study With Ipilimumab for Patients With Advanced Malignant Melanoma.
Active, not recruiting · NCT02068196 · Registry updated 2023-03-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A National Phase IV Study With Ipilimumab for Patients With Advanced Malignant Melanoma. | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm | Active, not recruiting | Phase 4 | 2023-03-24 | NCT02068196 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Oslo University Hospital | 327 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Haukeland University Hospital | Bergen | Norway | 52 |
| Nordland Hospital Bodø | Bodø | Norway | 2 |
| Oslo University Hospital | Oslo | Norway | 111 |
| Stavanger University Hospital | Stavanger | Norway | 36 |
| Sørlandet Hospital, Kristiansand | Kristiansand | Norway | 1 |
| Trondheim University Hospital, St.Olavs Hospital | Trondheim | Norway | 1 |
| University Hospital of North Norway | Tromsø | Norway | 18 |
| Ålesund Hospital | Ålesund | Norway | 10 |